Preparation and antitrypanosomal activity of secochiliolide acid derivatives

Secochiliolide acid (1) isolated from the Patagonian shrub Nardophyllum bryoides, was used as a scaffold for the preparation of a series of nine derivatives. Compound 1 and its derivatives were tested against Trypanosoma cruzi epimastigotes grown in liquid media. It was first observed that secochili...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Siless, G.E., Lozano, E., Sánchez, M., Mazzuca, M., Sosa, M.A., Palermo, J.A.
Formato: JOUR
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_0960894X_v23_n17_p4964_Siless
Aporte de:
id todo:paper_0960894X_v23_n17_p4964_Siless
record_format dspace
spelling todo:paper_0960894X_v23_n17_p4964_Siless2023-10-03T15:54:02Z Preparation and antitrypanosomal activity of secochiliolide acid derivatives Siless, G.E. Lozano, E. Sánchez, M. Mazzuca, M. Sosa, M.A. Palermo, J.A. Nardophyllum bryoides trypanocidal activity Secochiliolide acid Trypanosoma cruzi antitrypanosomal agent benznidazole carboxyl group exocyclic double bond furan secochiliolide acid derivative spironolactone unclassified drug article drug activity drug bioavailability drug synthesis epimastigote epoxidation high performance liquid chromatography IC 50 medicinal plant Nardophyllum bryoides nonhuman shrub Trypanosoma cruzi Nardophyllum bryoides Trypanosoma cruzi Nardophyllum bryoides Secochiliolide acid trypanocidal activity Trypanosoma cruzi Asteraceae Chagas Disease Diterpenes Humans Propionates Trypanocidal Agents Trypanosoma cruzi Secochiliolide acid (1) isolated from the Patagonian shrub Nardophyllum bryoides, was used as a scaffold for the preparation of a series of nine derivatives. Compound 1 and its derivatives were tested against Trypanosoma cruzi epimastigotes grown in liquid media. It was first observed that secochiliolide acid (1) inhibited the proliferation of the parasites, with an IC50 of 2 μg/mL. Six of the synthesized derivatives were also active with IC50's between 2 and 7 μg/mL which are comparable to that of the commercial drug benznidazole (2.5 μg/mL). These results indicate that the carboxyl group is not essential for the bioactivity of 1, while the presence of the tetrasubstituted exocyclic double bond seems to be important. Moreover, the presence of the furan and spirolactone rings is not essential for the bioactivity per se, but is important in combination with other structural fragments present in the molecule. © 2013 Elsevier Ltd. All rights reserved. Fil:Siless, G.E. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Palermo, J.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_0960894X_v23_n17_p4964_Siless
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Nardophyllum bryoides trypanocidal activity
Secochiliolide acid
Trypanosoma cruzi
antitrypanosomal agent
benznidazole
carboxyl group
exocyclic double bond
furan
secochiliolide acid derivative
spironolactone
unclassified drug
article
drug activity
drug bioavailability
drug synthesis
epimastigote
epoxidation
high performance liquid chromatography
IC 50
medicinal plant
Nardophyllum bryoides
nonhuman
shrub
Trypanosoma cruzi
Nardophyllum bryoides
Trypanosoma cruzi
Nardophyllum bryoides
Secochiliolide acid
trypanocidal activity
Trypanosoma cruzi
Asteraceae
Chagas Disease
Diterpenes
Humans
Propionates
Trypanocidal Agents
Trypanosoma cruzi
spellingShingle Nardophyllum bryoides trypanocidal activity
Secochiliolide acid
Trypanosoma cruzi
antitrypanosomal agent
benznidazole
carboxyl group
exocyclic double bond
furan
secochiliolide acid derivative
spironolactone
unclassified drug
article
drug activity
drug bioavailability
drug synthesis
epimastigote
epoxidation
high performance liquid chromatography
IC 50
medicinal plant
Nardophyllum bryoides
nonhuman
shrub
Trypanosoma cruzi
Nardophyllum bryoides
Trypanosoma cruzi
Nardophyllum bryoides
Secochiliolide acid
trypanocidal activity
Trypanosoma cruzi
Asteraceae
Chagas Disease
Diterpenes
Humans
Propionates
Trypanocidal Agents
Trypanosoma cruzi
Siless, G.E.
Lozano, E.
Sánchez, M.
Mazzuca, M.
Sosa, M.A.
Palermo, J.A.
Preparation and antitrypanosomal activity of secochiliolide acid derivatives
topic_facet Nardophyllum bryoides trypanocidal activity
Secochiliolide acid
Trypanosoma cruzi
antitrypanosomal agent
benznidazole
carboxyl group
exocyclic double bond
furan
secochiliolide acid derivative
spironolactone
unclassified drug
article
drug activity
drug bioavailability
drug synthesis
epimastigote
epoxidation
high performance liquid chromatography
IC 50
medicinal plant
Nardophyllum bryoides
nonhuman
shrub
Trypanosoma cruzi
Nardophyllum bryoides
Trypanosoma cruzi
Nardophyllum bryoides
Secochiliolide acid
trypanocidal activity
Trypanosoma cruzi
Asteraceae
Chagas Disease
Diterpenes
Humans
Propionates
Trypanocidal Agents
Trypanosoma cruzi
description Secochiliolide acid (1) isolated from the Patagonian shrub Nardophyllum bryoides, was used as a scaffold for the preparation of a series of nine derivatives. Compound 1 and its derivatives were tested against Trypanosoma cruzi epimastigotes grown in liquid media. It was first observed that secochiliolide acid (1) inhibited the proliferation of the parasites, with an IC50 of 2 μg/mL. Six of the synthesized derivatives were also active with IC50's between 2 and 7 μg/mL which are comparable to that of the commercial drug benznidazole (2.5 μg/mL). These results indicate that the carboxyl group is not essential for the bioactivity of 1, while the presence of the tetrasubstituted exocyclic double bond seems to be important. Moreover, the presence of the furan and spirolactone rings is not essential for the bioactivity per se, but is important in combination with other structural fragments present in the molecule. © 2013 Elsevier Ltd. All rights reserved.
format JOUR
author Siless, G.E.
Lozano, E.
Sánchez, M.
Mazzuca, M.
Sosa, M.A.
Palermo, J.A.
author_facet Siless, G.E.
Lozano, E.
Sánchez, M.
Mazzuca, M.
Sosa, M.A.
Palermo, J.A.
author_sort Siless, G.E.
title Preparation and antitrypanosomal activity of secochiliolide acid derivatives
title_short Preparation and antitrypanosomal activity of secochiliolide acid derivatives
title_full Preparation and antitrypanosomal activity of secochiliolide acid derivatives
title_fullStr Preparation and antitrypanosomal activity of secochiliolide acid derivatives
title_full_unstemmed Preparation and antitrypanosomal activity of secochiliolide acid derivatives
title_sort preparation and antitrypanosomal activity of secochiliolide acid derivatives
url http://hdl.handle.net/20.500.12110/paper_0960894X_v23_n17_p4964_Siless
work_keys_str_mv AT silessge preparationandantitrypanosomalactivityofsecochiliolideacidderivatives
AT lozanoe preparationandantitrypanosomalactivityofsecochiliolideacidderivatives
AT sanchezm preparationandantitrypanosomalactivityofsecochiliolideacidderivatives
AT mazzucam preparationandantitrypanosomalactivityofsecochiliolideacidderivatives
AT sosama preparationandantitrypanosomalactivityofsecochiliolideacidderivatives
AT palermoja preparationandantitrypanosomalactivityofsecochiliolideacidderivatives
_version_ 1807323248026714112